Cargando…
Quantification of subtype purity in Luminal A breast cancer predicts clinical characteristics and survival
PURPOSE: PAM50 profiling assigns each breast cancer to a single intrinsic subtype based on a bulk tissue sample. However, individual cancers may show evidence of admixture with an alternate subtype that could affect prognosis and treatment response. We developed a method to model subtype admixture u...
Autores principales: | Kumar, Neeraj, Gann, Peter H., McGregor, Stephanie M., Sethi, Amit |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10241706/ https://www.ncbi.nlm.nih.gov/pubmed/37209182 http://dx.doi.org/10.1007/s10549-023-06961-9 |
Ejemplares similares
-
Quantification of intrinsic subtype ambiguity in Luminal A breast cancer and its relationship to clinical outcomes
por: Kumar, Neeraj, et al.
Publicado: (2019) -
Ki-67 (30-9) scoring and differentiation of Luminal A- and Luminal B-like breast cancer subtypes
por: Viale, Giuseppe, et al.
Publicado: (2019) -
A high-risk luminal A dominant breast cancer subtype with increased mobility
por: Guo, Liping, et al.
Publicado: (2019) -
Utility of (18)F FDG-PET/CT for predicting prognosis of luminal-type breast cancer
por: Aogi, Kenjiro, et al.
Publicado: (2015) -
Breast cancer incidence and survival in Scotland by socio-economic deprivation and tumour subtype
por: Mesa-Eguiagaray, Ines, et al.
Publicado: (2022)